Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: "it's a numbers game"-implications for WNT medulloblastoma dose-reduction clinical trials.

ABSTRACT:

SUBMITTER: Gottardo NG 

PROVIDER: S-EPMC9807471 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature